Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
Go back to Myriad Genetics Forms Strategic Partnership with Illumina in Oncology| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 213.24 +8.24 (4.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $205.00 | 52 Week High | $196.47 | |||
| Open | $200.30 | 52 Week Low | $127.10 | |||
| Day High | $220.32 | P/E | 236.93 | |||
| Day Low | $200.30 | EPS | $0.90 | |||
| Volume | 3,284,556 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.22 +0.03 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.19 | 52 Week High | $45.34 | |||
| Open | $3.17 | 52 Week Low | $15.92 | |||
| Day High | $3.30 | P/E | 1.38 | |||
| Day Low | $3.14 | EPS | $2.33 | |||
| Volume | 1,928,369 | |||||
